Tazemetostat is an oral inhibitor of the enzyme enhancer of zeste homolog 2 (EZH2), which is involved in gene silencing. It is utilized in the treatment of certain cancers, including epithelioid sarcoma and follicular lymphoma. By inhibiting EZH2, it reactivates tumor suppressor genes and impedes cancer cell proliferation.
Cleanchem is a trusted provider of premium pharmaceutical reference materials, specializing in Tazemetostat and its associated compounds. Our catalog includes pharmacopeial and non-pharmacopeial Tazemetostat impurities, metabolites, nitrosamine derivatives (N-NO compounds), and stable isotope-labeled products. These reference standards play a critical role in pharmaceutical R&D, supporting activities such as product formulation, ANDA and DMF submissions, quality assurance, analytical method development, and stability assessments.
All Tazemetostat-related substances undergo comprehensive characterization and are delivered with complete Certificates of Analysis and supporting analytical documentation to ensure regulatory adherence. Upon request, we can offer EP/USP traceable standards. Our products are routinely re-evaluated to maintain consistent quality and performance.
English
Arabic
Chinese (Simplified)
French
Japanese
Portuguese
Russian
Spanish
